Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $6.83 million. The enterprise value is -$2.54 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 4.56 million shares outstanding. The number of shares has increased by 1,197.87% in one year.
| Current Share Class | 4.56M |
| Shares Outstanding | 4.56M |
| Shares Change (YoY) | +1,197.87% |
| Shares Change (QoQ) | +66.32% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 7.63% |
| Float | 4.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| Forward PS | 0.18 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.00 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.65% and return on invested capital (ROIC) is -13.52%.
| Return on Equity (ROE) | -25.65% |
| Return on Assets (ROA) | -11.18% |
| Return on Invested Capital (ROIC) | -13.52% |
| Return on Capital Employed (ROCE) | -20.77% |
| Revenue Per Employee | $698,880 |
| Profits Per Employee | -$121,281 |
| Employee Count | 52 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 2.25 |
Taxes
| Income Tax | -162,847 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.92% in the last 52 weeks. The beta is 0.24, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -47.92% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 2.10 |
| Relative Strength Index (RSI) | 52.54 |
| Average Volume (20 Days) | 59,102 |
Short Selling Information
The latest short interest is 295,667, so 6.49% of the outstanding shares have been sold short.
| Short Interest | 295,667 |
| Short Previous Month | 305,900 |
| Short % of Shares Out | 6.49% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, SBFM had revenue of $36.34 million and -$6.31 million in losses. Loss per share was -$2.71.
| Revenue | 36.34M |
| Gross Profit | 12.11M |
| Operating Income | -5.48M |
| Pretax Income | -3.72M |
| Net Income | -6.31M |
| EBITDA | -5.21M |
| EBIT | -5.48M |
| Loss Per Share | -$2.71 |
Full Income StatementBalance Sheet
The company has $10.31 million in cash and $929,026 in debt, giving a net cash position of $9.38 million or $2.06 per share.
| Cash & Cash Equivalents | 10.31M |
| Total Debt | 929,026 |
| Net Cash | 9.38M |
| Net Cash Per Share | $2.06 |
| Equity (Book Value) | 25.68M |
| Book Value Per Share | 5.63 |
| Working Capital | 22.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.76 million and capital expenditures -$787,095, giving a free cash flow of -$8.54 million.
| Operating Cash Flow | -7.76M |
| Capital Expenditures | -787,095 |
| Free Cash Flow | -8.54M |
| FCF Per Share | -$1.88 |
Full Cash Flow StatementMargins
Gross margin is 33.33%, with operating and profit margins of -15.08% and -17.35%.
| Gross Margin | 33.33% |
| Operating Margin | -15.08% |
| Pretax Margin | -17.80% |
| Profit Margin | -17.35% |
| EBITDA Margin | -14.35% |
| EBIT Margin | -15.08% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,197.87% |
| Shareholder Yield | -1,197.87% |
| Earnings Yield | -92.28% |
| FCF Yield | -125.00% |
Analyst Forecast
The average price target for SBFM is $15.00, which is 900.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 900.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |